A looming Texas court decision on abortion pills could impact nationwide access to medication, Vice President Kamala Harris warned Friday, as she described abortion access as a “constitutional right.”
The decision — which could be handed down as early as Friday — could yank mifepristone off the market more than two decades after the pill, also used to treat miscarriage, was approved by the Food and Drug Administration.
“This is not just an attack on women’s fundamental freedoms. It is an attack on the very foundation of our public health system,” Harris said during a White House meeting. . She was joined by American Academy of Family Physicians President Tochi Iroku-Malize, American College of Obstetricians and Gynecologists CEO Maureen Phipps, and other reproductive rights advocates and doctors groups.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect